Deepak Sampath

Company: Ultragenyx Pharmaceuticals

Job title: Senior Vice President, Head of Research

Seminars:

Panel Discussion: Brain Shuttles Beyond TFR1: What Will Be the Next Hot Brain Shuttle? 3:30 pm

Evaluate the opportunities in overcoming target delivery challenges with TfR1 overexpression and off-target specificity Explore small molecules, APOE1 peptides, nanopeptides, carbohydrates, LNPs as alternative ligands comparing pros, cons and negatives; evaluating opportunities where different ligands might be more ‘fit-for-purpose’Read more

day: Day 2